Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Assets: 2020-2025

Historic Non-Current Assets for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $523.3 million.

  • Maravai Lifesciences Holdings' Non-Current Assets fell 12.65% to $523.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $523.3 million, marking a year-over-year decrease of 12.65%. This contributed to the annual value of $579.1 million for FY2024, which is 26.47% down from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Non-Current Assets is $523.3 million, which was down 2.58% from $537.2 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Non-Current Assets' 5-year high stood at $1.6 billion during Q3 2023, with a 5-year trough of $523.3 million in Q3 2025.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Non-Current Assets value was $762.2 million (recorded in 2024), while the average stood at $893.7 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Non-Current Assets skyrocketed by 53.75% in 2022 and then crashed by 61.76% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Non-Current Assets (Quarterly) stood at $1.2 billion in 2021, then increased by 21.74% to $1.4 billion in 2022, then slumped by 45.10% to $787.5 million in 2023, then fell by 26.47% to $579.1 million in 2024, then declined by 12.65% to $523.3 million in 2025.
  • Its Non-Current Assets was $523.3 million in Q3 2025, compared to $537.2 million in Q2 2025 and $583.5 million in Q1 2025.